BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24367927)

  • 21. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells.
    Dunican DS; Mjoseng HK; Duthie L; Flyamer IM; Bickmore WA; Meehan RR
    BMC Biol; 2020 Mar; 18(1):25. PubMed ID: 32131813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
    Wu KJ; Yang MH
    Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
    Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
    Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3.
    Prickaerts P; Adriaens ME; Beucken TVD; Koch E; Dubois L; Dahlmans VEH; Gits C; Evelo CTA; Chan-Seng-Yue M; Wouters BG; Voncken JW
    Epigenetics Chromatin; 2016; 9():46. PubMed ID: 27800026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
    Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
    Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells.
    Muñoz DP; Lee EL; Takayama S; Coppé JP; Heo SJ; Boffelli D; Di Noia JM; Martin DI
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E2977-86. PubMed ID: 23882083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluripotency factors and Polycomb Group proteins repress aryl hydrocarbon receptor expression in murine embryonic stem cells.
    Ko CI; Wang Q; Fan Y; Xia Y; Puga A
    Stem Cell Res; 2014 Jan; 12(1):296-308. PubMed ID: 24316986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells.
    Weyemi U; Redon CE; Sethi TK; Burrell AS; Jailwala P; Kasoji M; Abrams N; Merchant A; Bonner WM
    Cell Cycle; 2016 Sep; 15(18):2398-404. PubMed ID: 27315462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications.
    Wu CY; Hung JJ; Wu KJ
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):668-73. PubMed ID: 21883379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
    Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
    Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
    Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
    Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition.
    McDonald OG; Wu H; Timp W; Doi A; Feinberg AP
    Nat Struct Mol Biol; 2011 Jul; 18(8):867-74. PubMed ID: 21725293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genes upregulated in the amnion at labour are bivalently marked by activating and repressive histone modifications.
    Mitchell CM; Hirst JJ; Mitchell MD; Murray HG; Zakar T
    Mol Hum Reprod; 2019 Apr; 25(4):228-240. PubMed ID: 30753586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.